CHAM, Switzerland, Nov. 13 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its November 2022 edition:

Systematic Reviews:

* The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis